Avenue Biosciences

United States · Biotech · AI · Enterprise software

Develops high-throughput protein engineering technology for biologics manufacturing

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed+$5.7MBalnord — Role not disclosedDimerent — Role not disclosedInventure — Role not disclosedTesi — Role not disclosedUniversity of Helsinki — Role not disclosedVoima Ventures — Role not disclosed
Sourcesavenuebiosciences.com ↗